Cresco Labs and Kiva Confections launch partnership in Illinois
CHICAGO, May 8, 2017 /PRNewswire/ — Cresco Labs, Illinois’ largest Medical Cannabis Brand is proud to announce a partnership bringing skillfully crafted Kiva Confections chocolate bars and terra bites to the patients of Illinois.
CEO and Co-Founder of Cresco Labs, Charlie Bachtell says, “Kiva Confections was the obvious choice in seeking an addition to our brand portfolio in Illinois. They adhere to the same high standards of product quality and innovation that our company is known for.”
May 3rd marks the official launch and availability of 5 chocolately medicated products from California’s largest edibles brand.
CHOCOLATE BARS:
Kiva’s original confection are brought to Illinois in 100mg bars available in three flavors: Dark Chocolate Blackberry, Milk Chocolate Mint Irish Cream and Milk Chocolate Vanilla Chai.
TERRA BITES:
A San Francisco Patients Choice award winner, Terra Bites chocolate covered espresso beans and blueberries and the ultimate delicious way to practice micro-dosing with 20, 5mg bites available in each tin.
These exciting products expand Cresco Labs’ already exceptional line of medicated edibles which includes a collaboration by Chef Mindy Segal of Hot Chocolate Restaurant and a line of charitable edibles that donate a portion of profits to charity called Cresco Cares. With all of their products, Cresco Labs maintains consistent and accurate dosing along with great taste.
“Kiva Confections’ partnership with Cresco Labs ensures that we provide the same safe, effective, and consistent medicine to Illinois patients that we are known for in California, Arizona and Nevada.” Kristi Knoblich Palmer, COO and Co-Founder, Kiva Confections
Kiva products, Mindy’s Edibles and Cresco Cares gummies can be found in Illinois dispensaries. For more information go to crescolabs.com, kivaconfections.com or mindysedibles.com.
Cresco Labs is based in Illinois and operates as part of the state’s Medical Cannabis Pilot Program. For more information on the company or the state program, please visit www.crescolabs.com. For additional press inquiries, please email press@crescolabs.com.
